J. Ansari

Evolving pharmacotherapy in Alzheimer’s disease: from symptomatic management to disease modification-A PRISMA 2020-guided narrative review

Alzheimer’s disease (AD) is the leading cause of dementia worldwide and poses an increasing challenge for ageing populations. For decades, pharmacologic management has relied on cholinesterase inhibitors and memantine, which provide modest symptomatic benefit without altering the underlying neurodegenerative process. R...